At a glance
ClinicalIndex Comparison RecordN/ACompleted· 18 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of the Pharmacokinetics and Pharmacodynamics of Ganciclovir in Premature Infants Receiving Treatment for Cytomegalovirus Infection
In Brief
An observational study for Cytomegalovirus Infections. Completed, enrolled 18 participants across 15 sites.
Detailed Summary
This is a clinical sampling study, and no study drugs will be administered under this protocol. Premature infants who receive intravenous ganciclovir as part of clinical care will be eligible for participation in this study. Intravenous ganciclovir will not be provided under this protocol.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCytomegalovirus Infections
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedMay 2012
Enrollment StartApr 2013
Primary CompletionMar 2019
TodayJul 2026
First PostedMay 21, 2012
Enrollment StartApr 1, 2013
Primary CompletionMar 1, 2019
TodayJul 2, 2026
Enrollment to primary: 5.9 yearsPosted 14.1 years ago